Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists
Hitoshi Kohsaka(Tokyo Medical and Dental University), Takayuki Sumida(University of Tsukuba), Hiroyuki Tomimitsu(Tokyo Medical and Dental University), Yoshihide Sunada(Kawasaki Medical School), Masatoshi Jinnin(Wakayama Medical University), Yoshinao Muro(Nagoya University), Akiko Ohta(Saitama Medical University), Jun Shimizu(Shimane University), Takashi Kanda(Yamaguchi University), Yasushi Kawaguchi(Tokyo Women's Medical University), Manabu Fujimoto(Osaka Gakuin University), Shoichiro Ishihara(National Defense Medical College), Tsuneyo Mimori(Kyoto University)
Cited by 85
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438